The interplay between TGF-β and VEGF signalling in endothelial cell function

Abstract

The transforming growth factor (TGF)-_ signalling pathway plays a major role in angiogenesis. Aberration of the TGF-_ signalling cascade leads to abnormal remodelling and maturation of the primitive vascular plexus and decreased vessel wall integrity in adults. Targeted deletion of TGF-_ signalling receptors in mice, such as ALK1, ALK5, T_RII or endoglin, results in embryonic lethality due to impaired vascular development. In humans, mutations in ALK1, ALK5, T_RII or endoglin are associated with human vascular diseases such as HHT and pulmonary hypertension (PAH). Vascular endothelial growth factor (VEGF) is a multifunctional molecule that is involved in vascular growth and remodeling. Perturbation in VEGF signalling also contributes to the pathology of tumor angiogenesis and cardiovascular diseases in humans. This thesis is focused on the characterization of the crosstalk between the TGF-_ and VEGF signalling pathways, on EC function, the effect of bone morphogenetic protein (BMP)9 on EC function and the role of endoglin in VEGF-induced angiogenesis. The results of these studies may give us insights into the impacts/effects of these two angiogenic signalling cascades on EC function. This can be beneficial for the understanding of the etiology of certain vascular diseases and the development of new treatment modalities in the future